[go: up one dir, main page]

AU2003219313A1 - Chemokines and uses thereof - Google Patents

Chemokines and uses thereof

Info

Publication number
AU2003219313A1
AU2003219313A1 AU2003219313A AU2003219313A AU2003219313A1 AU 2003219313 A1 AU2003219313 A1 AU 2003219313A1 AU 2003219313 A AU2003219313 A AU 2003219313A AU 2003219313 A AU2003219313 A AU 2003219313A AU 2003219313 A1 AU2003219313 A1 AU 2003219313A1
Authority
AU
Australia
Prior art keywords
chemokines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003219313A
Inventor
Gerry Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Publication of AU2003219313A1 publication Critical patent/AU2003219313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003219313A 2002-04-02 2003-04-02 Chemokines and uses thereof Abandoned AU2003219313A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0207624.8A GB0207624D0 (en) 2002-04-02 2002-04-02 Chemokine and uses thereof
GB0207624.8 2002-04-02
PCT/GB2003/001472 WO2003082920A1 (en) 2002-04-02 2003-04-02 Chemokines and uses thereof

Publications (1)

Publication Number Publication Date
AU2003219313A1 true AU2003219313A1 (en) 2003-10-13

Family

ID=9934125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003219313A Abandoned AU2003219313A1 (en) 2002-04-02 2003-04-02 Chemokines and uses thereof

Country Status (3)

Country Link
AU (1) AU2003219313A1 (en)
GB (1) GB0207624D0 (en)
WO (1) WO2003082920A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2618951A1 (en) 2005-08-12 2007-02-22 Schering Corporation Mcp1 fusions
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
CN118459548B (en) * 2024-07-09 2024-10-18 同宜医药(苏州)有限公司 Polypeptide targeting epidermal growth factor receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495518B1 (en) * 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells

Also Published As

Publication number Publication date
WO2003082920A1 (en) 2003-10-09
GB0207624D0 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
EP1539941A4 (en) Adzymes and uses thereof
AU2003272187A1 (en) Novel nanoparticles and use thereof
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2003270341A1 (en) Modified asialo-interferons and uses thereof
AU2003265202A1 (en) Novel lactams and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2003216221A1 (en) Attachment and articles using same
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002230036A1 (en) Glucosamine-polyacrylate inter-polymer complex and applications thereof
AU2003271183A1 (en) Block copolymer and application thereof
AU2003299943A1 (en) Heterocycles and uses thereof
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003298739A1 (en) Intermedin and its uses
AU2003228355A1 (en) Adipocytes and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003219313A1 (en) Chemokines and uses thereof
AU2003263326A1 (en) Foxp1 and uses thereof
AU2003300396A1 (en) Chemokine antagonists and uses thereof
AU2003250881A1 (en) Polymeric blends and use thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003300859A1 (en) Carrier-ligand fusions and uses thereof
AU2003216442A1 (en) Enkurin and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase